查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1901514

失眠補充劑市場：按劑型、來源、產品、配銷通路、國家和地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Insomnia Supplements Market, By Dosage Form, By Source, By Product, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年失眠補充劑市場規模價值 43.5698 億美元，從 2025 年到 2032 年以 13.2% 的複合年成長率成長。

失眠補充劑是一種無需處方即可購買的產品，旨在幫助人們更快入睡、延長睡眠時間並改善整體睡眠品質。它們通常含有褪黑素、鎂、草藥萃取物、胺基酸或大麻素等成分，這些成分能夠促進放鬆並調節睡眠週期。對於那些尋求天然或溫和方法來改善偶發性或慢性睡眠問題的消費者而言，這些補充劑提供了一種非處方選擇。不斷上升的壓力水平和人們對天然助眠產品的日益青睞正在推動失眠補充劑市場的發展。一個關鍵趨勢是使用將褪黑素與植物成分結合的多功能配方，以提高其功效。然而，監管不力以及對產品品質的擔憂仍然限制著市場成長。儘管如此，不斷成長的電子商務分銷管道和對個人化睡眠解決方案的需求為品牌創新和拓展更廣泛的消費群體提供了巨大的機會。

失眠補充劑市場－市場動態

慢性病盛行率上升將推動市場成長

慢性病盛行率的上升預計將推動失眠補充劑市場的未來成長。慢性病是指持續三個月或更長時間且病情可能隨時間惡化的疾病。患有心血管疾病、糖尿病和慢性疼痛等慢性疾病的患者，常伴隨失眠或其他睡眠相關問題。這種盛行率的上升催生了對有效失眠治療和管理策略的需求，從而推動了睡眠障礙相關產品和服務市場的發展。根據美國國家醫學圖書館下屬的國家生物技術資訊中心（NCBI）的數據顯示，到2050年，全球將有1.4266億人患有慢性病，高於2020年的7,152.2萬人。因此，慢性病盛行率的上升推動了失眠補充劑產業的成長。

失眠補充劑市場區隔分析：

全球失眠補充劑市場按劑型、來源、產品、配銷通路和地區細分。

根據產品細分市場，褪黑素類補充劑是失眠補充劑市場中最受歡迎的細分市場，這主要得益於消費者對非成癮性助眠產品的需求不斷成長。褪黑素能夠調節晝夜節律，影響血清素等情緒調節神經傳導物質。這種雙重功效，加上其促進睡眠的能力，使其成為焦慮相關睡眠障礙或一般壓力族群的理想選擇。由於送貨上門的便利性和日益增強的健康意識，褪黑素在網路藥局和電商平台的銷售量顯著成長。 2023年1月，寶潔健康在印度推出了Vicks ZzzQuil NATURA，這是一款添加褪黑素的軟糖，旨在幫助用戶快速入睡，且不會導致隔天困倦。該產品還含有維生素B6，有助於減輕疲勞感，並添加了天然洋甘菊和薰衣草成分，以促進放鬆。此次產品上市滿足了一項重大需求，因為寶潔健康發現，只有 15% 的印度人晚上能睡個好覺，而近 60% 的人偶爾會失眠。

以劑型分類，膠囊在失眠補充品市場應用廣泛，憑藉其便利性、劑量可控性和消費者偏好度高，已成為最大的細分市場。膠囊更容易吞嚥和崩解，使褪黑素、纈草根和L-茶氨酸等活性成分能夠更快被吸收。這種劑型也便於進行精確配方和控釋，因此深受尋求可靠穩定效果的生產商和使用者的青睞。此外，膠囊的保存期限更長，通常不含添加糖或人工香料，符合清潔標籤的趨勢。 2024年12月，Sleepinox.com推出了一款天然睡眠補充劑，配方包含纈草根、琉璃苣、南非醉茄和甘氨酸鎂。該產品以90粒膠囊的瓶裝形式在網路上銷售，旨在促進安穩、恢復精力的睡眠。

失眠補充劑市場—地域分佈洞察

北美是失眠補充劑（ED​​藥物）市場的重要收入來源地，這主要歸功於該地區睡眠障礙的高發生率以及民眾日益增強的健康意識。根據美國國家老化委員會統計，美國有5,000萬至7,000萬人患有慢性睡眠障礙，其中以失眠最為常見。如此高的需求促使企業不斷創新，拓展產品線，以滿足睡眠不足的消費者的需求。例如，GNC於2023年5月推出了其預防營養睡眠支援產品，該產品專注於改善認知功能，特別是睡眠、注意力和壓力管理。人們對健康和保健日益重視，以及線上藥局的便利性，都有助於推動該地區市場的成長。

美國失眠補充劑市場—國家概況

由於高壓力、快節奏的生活方式以及人們對睡眠健康的日益關注，美國已成為失眠補充劑市場最大、最具活力的市場之一。消費者對天然、非處方助眠產品（例如褪黑素、鎂和草藥混合物）的強烈需求，正在推動市場成長。根據美國睡眠醫學會最近的一項調查，約30%的美國成年人表示入睡或保持睡眠困難，10%的人患有慢性失眠，12%的人被醫生診斷為慢性失眠。這些產品的廣泛普及推高了對有效非處方補充劑的需求，而強勁的線上零售滲透率和人們對個人化健康產品日益成長的興趣也進一步促進了這一需求。

目錄

第1章：失眠補充劑市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
  • 競爭洞察

第3章：失眠補充劑市場主要趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場未來趨勢

第4章：失眠補充劑產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：失眠補充劑市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：失眠補充劑市場概況

  • 2024年失眠補充劑市佔率分析
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：失眠補充劑市場：以劑型分類

  • 概述
    • 細分市場佔有率分析：按劑型
    • 片劑
    • 液體
    • 膠囊
    • 粉末
    • 其他

第8章：失眠補充劑市場：依來源分類

  • 概述
    • 細分市場佔有率分析：按來源
    • 自然的
    • 合成的

第9章：失眠補充劑市場：依產品分類

  • 概述
    • 細分市場佔有率分析：依產品
    • 礦物
    • 纈草根
    • 維他命
    • 褪黑素
    • 其他

第10章：失眠補充劑市場：依配銷通路分類

  • 概述
    • 細分市場佔有率分析：按來源
    • 醫院藥房
    • 網路藥局
    • 零售藥局
    • 專賣店

第11章：失眠補充品市場：依地域分類

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • その他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • その他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • その他

第12章：主要供應商分析：失眠補充劑產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Nature's Bounty
    • Nestle
    • Zarbee's Naturals
    • Olly
    • Herbalife Nutrition Ltd
    • Hims & Hers Health, Inc.
    • NOW Foods
    • Bayer
    • Herb Pharm
    • Natrol, LLC
    • Others

第13章：360度AnalystView

簡介目錄
Product Code: ANV5824

Insomnia Supplements Market size was valued at US$ 4,356.98 Million in 2024, expanding at a CAGR of 13.2% from 2025 to 2032.

Insomnia supplements are over-the-counter products that help people fall asleep faster, stay asleep longer, and sleep better overall. They usually contain ingredients like melatonin, magnesium, herbal extracts, amino acids, or cannabinoids, which promote relaxation and regulate sleep cycles. These supplements provide a non-prescription alternative for people looking for natural or gentle support for occasional or chronic sleep problems. Rising stress levels and a growing preference for natural sleep aids are driving the Insomnia Supplements market. A key trend is the use of multifunctional formulas that combine melatonin with botanicals to increase efficacy. However, inconsistent regulatory oversight and concerns about product quality continue to limit market growth. Despite this, growing e-commerce distribution and demand for personalized sleep solutions offer significant opportunities for brands to innovate and reach a larger consumer base.

Insomnia Supplements Market- Market Dynamics

Rising Prevalence of Chronic Diseases to Drive Market Growth

The rising prevalence of chronic diseases is expected to drive future growth in the insomnia supplements market. Chronic disease is a type of illness that lasts three months or longer and can deteriorate over time. Individuals with chronic diseases, such as cardiovascular disorders, diabetes, and chronic pain conditions, frequently have insomnia or other sleep-related problems as a comorbidity. This increased prevalence creates a demand for effective insomnia treatments and management strategies, which drives the market for sleep disorder-related products and services. According to the National Centre for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people living with chronic diseases by 2050, up from 71.522 million in 2020. As a result, the rising prevalence of chronic diseases fuels the growth of the insomnia supplements industry.

Insomnia Supplements Market- Segmentation Analysis:

The Global Insomnia Supplements Market is segmented by Dosage Form, Source, Product, Distribution Channel and Region.

According to the product segment, Melatonin-based supplements are the most popular segment of the insomnia supplements market, driven by rising consumer demand for non-addictive sleep aids. Melatonin regulates circadian rhythms and affects mood-regulating neurotransmitters such as serotonin. This dual benefit, combined with its ability to induce sleep, makes it an appealing option for people experiencing anxiety-related sleep disturbances or general stress. Melatonin sales increased significantly at online pharmacies and e-commerce platforms, owing to the convenience of home delivery and growing health awareness. In January 2023, P&G Health launched Vicks ZzzQuil NATURA in India, a melatonin-infused gummy designed to help users fall asleep quickly without causing drowsiness the next day. The product also contains vitamin B6, which helps to reduce tiredness and fatigue, and it is infused with natural chamomile and lavender to promote relaxation. This launch addresses a significant need, as P&G Health discovered that only 15% of Indians get adequate sleep at night, with nearly 60% experiencing occasional sleeplessness.

By Dosage Form, Capsules are widely used in the insomnia supplement market, emerging as the largest segment due to their convenience, controlled dosage, and high consumer preference. Capsules are easier to swallow and disintegrate, allowing for faster absorption of active ingredients such as melatonin, valerian root, and L-theanine. This form factor also allows for precise formulation and controlled-release options, making it popular with manufacturers and users looking for dependable and consistent results. Additionally, capsules have longer shelf lives and are frequently free of added sugars or artificial flavors, which aligns with clean-label trends. In December 2024, Sleepinox.com launched a natural sleep supplement formulated with valerian root, borage, ashwagandha and magnesium glycinate. The product is available online in a bottle with 90 capsules and aims to promote restful, rejuvenating sleep.

Insomnia Supplements Market- Geographical Insights

North America is a significant revenue-generating region in the Insomnia Supplements (ED) drugs market, owing primarily to the high prevalence of sleep disorders and rising health awareness among its population. According to the National Council on Aging, 50 to 70 million people in the United States have chronic sleep disorders, with insomnia being the most common. This high demand has prompted businesses to innovate and broaden their product offerings to meet the needs of sleep-deprived customers. For instance, in May 2023, GNC introduced its Preventive Nutrition Sleep Support products, which focus on improving cognitive function, particularly sleep, focus, and stress. The growing emphasis on health and wellness, as well as the convenience of online pharmacies, helps to drive market growth in this region.

United States Insomnia Supplements Market- Country Insights

The United States is one of the largest and most dynamic markets for insomnia supplements, due to high stress levels, hectic lifestyles, and a growing awareness of sleep health. The strong consumer shift toward natural, non-prescription sleep aids such as melatonin, magnesium, and herbal blends is driving market growth. According to a recent survey conducted by the American Academy of Sleep Medicine, approximately 30% of adults in the United States report difficulty falling or staying asleep, 10% suffer from chronic insomnia, and 12% have been medically diagnosed with chronic insomnia. This widespread availability drives up demand for effective over-the-counter supplements, which is bolstered by strong online retail penetration and growing interest in personalized wellness products.

Insomnia Supplements Market- Competitive Landscape:

The competitive landscape of the insomnia supplements market is characterized by the presence of numerous players, ranging from multinational pharmaceutical corporations to small and medium-sized businesses specializing in natural and herbal products. The market is highly fragmented, with companies seeking a competitive advantage through product innovation, quality, and marketing strategies. The growing demand for natural and safe sleep aid products has resulted in a surge of new entrants and the introduction of novel formulations, escalating competition.

Recent Developments:

In October 2025, Slumber introduced its Pure Sleep fast-acting gummies, which contain 20 mg of CBN and Azuca's Time Infusion(R) technology for rapid onset in minutes. The company developed the formula to help customers fall asleep faster, stay asleep longer, and wake up feeling refreshed.

In August 2025, AG1 introduced AGZ, a melatonin-free drink mix containing Magtein, saffron, and L-theanine that promotes relaxation and restorative sleep. The product was launched to support evening routines and supplement AG1's morning formula with all-day wellness benefits.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL INSOMNIA SUPPLEMENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Nature's Bounty
  • Nestle
  • Zarbee's Naturals
  • Olly
  • Herbalife Nutrition Ltd
  • Hims & Hers Health, Inc.
  • NOW Foods
  • Bayer
  • Herb Pharm
  • Natrol, LLC
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Liquid
  • Capsules
  • Powders
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Minerals
  • Valerian root
  • Vitamin
  • Melatonin
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Specialty Stores

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Insomnia Supplements Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Insomnia Supplements Market Snippet by Dosage Form
    • 2.1.2. Insomnia Supplements Market Snippet by Source
    • 2.1.3. Insomnia Supplements Market Snippet by Product
    • 2.1.4. Insomnia Supplements Market Snippet by Distribution Channel
    • 2.1.5. Insomnia Supplements Market Snippet by Country
    • 2.1.6. Insomnia Supplements Market Snippet by Region
  • 2.2. Competitive Insights

3. Insomnia Supplements Key Market Trends

  • 3.1. Insomnia Supplements Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Insomnia Supplements Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Insomnia Supplements Market Opportunities
  • 3.4. Insomnia Supplements Market Future Trends

4. Insomnia Supplements Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Insomnia Supplements Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Insomnia Supplements Market Landscape

  • 6.1. Insomnia Supplements Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Insomnia Supplements Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
    • 7.1.2. Tablets
    • 7.1.3. Liquid
    • 7.1.4. Capsules
    • 7.1.5. Powders
    • 7.1.6. Others

8. Insomnia Supplements Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 8.1.2. Natural
    • 8.1.3. Synthetic

9. Insomnia Supplements Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 9.1.2. Minerals
    • 9.1.3. Valerian root
    • 9.1.4. Vitamin
    • 9.1.5. Melatonin
    • 9.1.6. Others

10. Insomnia Supplements Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 10.1.2. Hospital Pharmacies
    • 10.1.3. Online Pharmacies
    • 10.1.4. Retail Pharmacies
    • 10.1.5. Specialty Stores

11. Insomnia Supplements Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Insomnia Supplements Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Insomnia Supplements Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Insomnia Supplements Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Insomnia Supplements Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Insomnia Supplements Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Insomnia Supplements Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Nature's Bounty
    • 12.2.2. Nestle
    • 12.2.3. Zarbee's Naturals
    • 12.2.4. Olly
    • 12.2.5. Herbalife Nutrition Ltd
    • 12.2.6. Hims & Hers Health, Inc.
    • 12.2.7. NOW Foods
    • 12.2.8. Bayer
    • 12.2.9. Herb Pharm
    • 12.2.10. Natrol, LLC
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us